DPW Holdings, Inc. (NYSE American: DPW) ("
DPW" or
the "
Company"), a diversified holding company,
announced today that it has provided, through a preferred
investment with certain privileges and rights, $1,000,000 to
Sandstone Diagnostic (“
Sandstone”). This
investment represents a 4.05% equity stake in the innovative
developer of point-of care medical testing equipment and systems.
Sandstone is the creator of Trak, www.trakfertility.com, the
leading male fertility tracker which has been clinically tested and
is FDA cleared for distribution. Trak is a consumer test kit and
mobile app for males that provides couples a simple and accurate
way to monitor and improve his fertility from the comfort and
privacy of their home. Trak utilizes its proprietary bio-analysis
platform to empower men to take control of their reproductive
health and improve a couple's chances of conception. Sandstone
Diagnostics is a Bay Area consumer health company focused on
leveraging innovative biotechnologies to develop instruments and
consumables for point-of-care medical testing that empower people
to measure and improve important health markers at home.
“DPW is an ideal strategic investor for Sandstone. Their broad
interests in the medical device space and innovative thinking are
additional assets they bring to the table,” stated Ms. Drexler.
“We are very excited about our investment in Sandstone
Diagnostics and look forward to supporting the work of the team led
by their CEO, Karen Drexler. Ms. Drexler is a proven driver of
change in Life Sciences and is an experienced and accomplished
businesswoman and mentor of investment. Karen has both the
entrepreneurial spirit and hardened corporate experience to surpass
the success we envision for Sandstone, said Milton “Todd” Ault,
III, the Company’s Chief Executive Officer and Chairman. Ault
continued, “Sandstone’s Trak provides couples an easy and proven
solution to improve man’s health and their ability to have
children. Sandstone represents another facet of our aggressive
investment and growth strategies that we’ll continue to execute
throughout 2018 as outlined during our webinar on December 20,
2017. We are moving methodically forward to expand our
collaborative opportunities and maximize our existing revenue
streams while creating new ones. DPW is focused on increasing
profitability and leveraging scale, all contributing to our goal of
providing shareholders long-term added-value and growth.”
The Company stated that Sandstone is the latest investment that
will be held by its Life Sciences division. Mr. Ault has over 20
years of experience in developing businesses in the Life Sciences
and the Medical Care sectors. Ranging from equity investment to
operating bio-tech start-ups and a developing medical safety
equipment manufacturer, Mr. Ault possesses a unique blend of
talents and expertise that culminated on February 25, 2016 in the
founding of Alzamend Neuro, Inc., a biotechnology firm dedicated to
finding the treatment, prevention and cure for Alzheimer’s Disease.
Mr. Ault has served as Chairman since Alzamend’s inception. As an
activist, Mr. Ault in the Spring of 2004 became the majority
shareholder of Franklin Capital Corp. and was elected to its board
of directors in July 2004. Subsequently on February 25, 2005, Mr.
Ault led Franklin Capital to acquire SurgiCount Medical, Inc., the
creator and developer of the SafetySponge® System; an FDA-cleared
bar coding technology for inventory control that aims to detect and
prevent the incidence of foreign objects left in the body after
surgery. In April 2005, Ault restructured Franklin Capital Corp.,
having it change its name to Patient Safety Technologies, Inc.
(AMEX: PSTX) (“PST”). Stryker Corporation (NYSE:SYK) acquired PST
at the beginning of 2014 in a cash deal valued at one hundred
twenty million dollars ($120,000,000).
The Company stated it would keep the market updated on any
developments or substantial changes in its investment in Sandstone
Diagnostics, Inc.
ABOUT DPW HOLDINGS, INC.
Headquartered in Fremont, CA, DPW Holdings, Inc. is a
diversified holding company that, through its wholly owned
subsidiary, Coolisys Technologies, Inc., is dedicated to providing
world-class technology-based solutions where innovation is the main
driver for mission-critical applications and lifesaving services.
Coolisys’ growth strategy targets core markets that are
characterized by “high barriers to entry” and include specialized
products and services not likely to be commoditized. Coolisys
through its portfolio companies develops and manufactures
cutting-edge resonant switching power topologies, specialized
complex high-frequency radio frequency (RF) and microwave
detector-log video amplifiers, very high-frequency filters and
naval power conversion and distribution equipment. Coolisys
services the defense, aerospace, medical and industrial sectors and
manages four entities including Digital Power Corporation,
www.DigiPwr.com, a leading manufacturer based in Northern
California, 1-877-634-0982; Digital Power Limited dba Gresham Power
Ltd., www.GreshamPower.com, a manufacturer based in Salisbury, UK.;
Microphase Corporation, www.MicroPhase.com with its headquarters in
Shelton, CT 1- 203-866-8000; and Power-Plus Technical Distributors,
www.Power-Plus.com, a wholesale distributor based in Sonora, CA
1-800-963-0066.
Digital Power Lending, LLC, a wholly owned subsidiary of the
Company, is based in Fremont, CA, and is a California private
lending company dedicated to strategically providing capital to
small and middle size businesses for an equity interest in addition
to loan fees and interest, www.DigitalPowerLending.com. Excelo,
LLC, a wholly-owned subsidiary of the Company, is a national search
firm specializing in fulfilling strategic executive, professional
and hi-tech placements for businesses delivering world-class
services, www.Excelo.com. DPW Holdings, Inc.’s headquarters is
located at 48430 Lakeview Blvd., Fremont, California, 94538;
1-877-634-0982; www.DPWHoldings.com.
For Investor inquiries: IR@DPWHoldings.com or
1-888-753-2235.
Forward-Looking Statements
The foregoing release contains “forward looking statements”
within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended, including statements regarding the
acquisition and the ability to consummate the
acquisition. These forward-looking statements generally
include statements that are predictive in nature and depend upon or
refer to future events or conditions, and include words such as
“believes,” “plans,” “anticipates,” “projects,” “estimates,”
“expects,” “intends,” “strategy,” “future,” “opportunity,” “may,”
“will,” “should,” “could,” “potential,” or similar expressions.
Statements that are not historical facts are forward-looking
statements. Forward-looking statements are based on current beliefs
and assumptions that are subject to risks and uncertainties.
Forward-looking statements speak only as of the date they are made,
and the Company undertakes no obligation to update any of them
publicly in light of new information or future events. Actual
results could differ materially from those contained in any
forward-looking statement as a result of various factors. More
information, including potential risk factors, that could affect
the Company’s business and financial results are included in the
Company’s filings with the U.S. Securities and Exchange Commission,
including, but not limited to, the Company’s Forms 10-K, 10-Q and
8-K. All filings are available at www.sec.gov and on the Company’s
website at www.DPWHoldings.com.
Ault Global (AMEX:DPW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ault Global (AMEX:DPW)
Historical Stock Chart
From Sep 2023 to Sep 2024